CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...

Calumet shows strong potential as a long-term investment with growth opportunities and positive cash flows. Click here to ...

Jungheinrich's guidance remains steady, though risks persist. Find out why JGHAF stock's valuation suggests upside potential, ...

I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...

Quantum Computing Inc. is a promising investment opportunity in the nascent quantum computing industry with strong growth ...

Learn about the recent changes in bond yields, the stock market, the U.S. Click here to find out more about bonds.

Palantir is susceptible to a general market decline, as earlier investors cash in on the bubble. Click here to find out why I ...

Quant titan Steven Cress shares his top stocks for 2025, beginning with Celestica (0:45). Intapp's very strong liquidity and ...

MongoDB’s growth accelerates with AI boom and enterprise focus. See why MDB stock could see 62% upside if it hits consensus ...

Learn about Healwell AI Inc.'s growth strategy in the healthcare AI sector in Canada, projected to reach USD $10.7 billion by ...

Financial writer recommends a soft buy rating on Brunswick Corporation despite recent underperformance. Click for this ...

Vanguard Growth Index Fund ETF Shares thrived in 2024, but economic changes raise concerns. See why we maintain a cautious ...